BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35698260)

  • 1. Mitochondrial genome mutations and neuronal dysfunction of induced pluripotent stem cells derived from patients with Alzheimer's disease.
    Lee Y; Kim M; Lee M; So S; Kang SS; Choi J; Kim D; Heo H; Lee SS; Park HR; Ko JJ; Song J; Kang E
    Cell Prolif; 2022 Jul; 55(7):e13274. PubMed ID: 35698260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial genome mutations in mesenchymal stem cells derived from human dental induced pluripotent stem cells.
    Park J; Lee Y; Shin J; Lee HJ; Son YB; Park BW; Kim D; Rho GJ; Kang E
    BMB Rep; 2019 Dec; 52(12):689-694. PubMed ID: 31234953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
    Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
    Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of iPSCs without mtDNA deletion for autologous cell therapy in a patient with Pearson syndrome.
    Lee Y; Han J; Hwang SB; Kang SS; Son HB; Jin C; Kim JE; Lee BH; Kang E
    BMB Rep; 2023 Aug; 56(8):463-468. PubMed ID: 37156631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
    Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional pancreatic cells differentiated from induced pluripotent stem cells with mitochondrial DNA mutations.
    So S; Lee S; Lee Y; Han J; Kang S; Choi J; Kim B; Kim D; Yoo HJ; Shim IK; Oh JY; Lee YN; Kim SC; Kang E
    BMB Rep; 2022 Sep; 55(9):453-458. PubMed ID: 35651332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell reprogramming shapes the mitochondrial DNA landscape.
    Wei W; Gaffney DJ; Chinnery PF
    Nat Commun; 2021 Sep; 12(1):5241. PubMed ID: 34475388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs.
    Palombo F; Peron C; Caporali L; Iannielli A; Maresca A; Di Meo I; Fiorini C; Segnali A; Sciacca FL; Rizzo A; Levi S; Suomalainen A; Prigione A; Broccoli V; Carelli V; Tiranti V
    Stem Cell Reports; 2021 Aug; 16(8):1953-1967. PubMed ID: 34329598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.
    Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM
    Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the mitochondrial signatures in ESCs and iPSCs and their neural derivations.
    Kristiansen CK; Chen A; Høyland LE; Ziegler M; Sullivan GJ; Bindoff LA; Liang KX
    Cell Cycle; 2022 Oct; 21(20):2206-2221. PubMed ID: 35815665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer's disease.
    Lomoio S; Pandey RS; Rouleau N; Menicacci B; Kim W; Cantley WL; Haydon PG; Bennett DA; Young-Pearse TL; Carter GW; Kaplan DL; Tesco G
    Mol Psychiatry; 2023 Dec; 28(12):5390-5401. PubMed ID: 37365240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
    Hatakeyama H; Goto Y
    Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.
    Yang J; Zhao H; Ma Y; Shi G; Song J; Tang Y; Li S; Li T; Liu N; Tang F; Gu J; Zhang L; Zhang Z; Zhang X; Jin Y; Le W
    Oncotarget; 2017 Jan; 8(5):7900-7913. PubMed ID: 27926491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs.
    Kang E; Wang X; Tippner-Hedges R; Ma H; Folmes CD; Gutierrez NM; Lee Y; Van Dyken C; Ahmed R; Li Y; Koski A; Hayama T; Luo S; Harding CO; Amato P; Jensen J; Battaglia D; Lee D; Wu D; Terzic A; Wolf DP; Huang T; Mitalipov S
    Cell Stem Cell; 2016 May; 18(5):625-36. PubMed ID: 27151456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
    Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
    Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.